{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:40:11Z","timestamp":1788964811850,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jdiacomp.2025.109144","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T06:37:49Z","timestamp":1753857469000},"page":"109144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Predicting the occurrence of DKA following sodium glucose co-transporter-2 inhibitors: An international cohort study"],"prefix":"10.1016","volume":"39","author":[{"given":"Michael","family":"Fralick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats C.","family":"H\u00f8jbjerg Lassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadish","family":"Rangrej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Rais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Hillmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie Lee","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Zorcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Colacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor","family":"Biering-S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Mamdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran R.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2025.109144_bb0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107704","article-title":"Lowering of hemoglobin A1C and risk of cardiovascular outcomes and all-cause mortality, a meta-regression analysis","volume":"34","author":"Fralick","year":"2020","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0025-7125(16)30082-7","article-title":"Diabetic ketoacidosis","volume":"79","author":"Kitabchi","year":"1995","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0020","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s11606-020-06561-z","article-title":"Identifying risk factors for diabetic ketoacidosis associated with SGLT2 inhibitors: a nationwide cohort study in the USA","volume":"36","author":"Fralick","year":"2021","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcjd.2021.04.006","article-title":"Sodium-glucose cotransporter-2 inhibitors and risk of diabetic ketoacidosis among adults with type 2 diabetes: a systematic review and meta-analysis","volume":"46","author":"Colacci","year":"2022","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0030","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/M20-0289","article-title":"Sodium-glucose cotransporter-2 inhibitors and the risk for diabetic ketoacidosis: a multicenter cohort study","volume":"173","author":"Douros","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0035","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1056\/NEJMc1701990","article-title":"Risk of diabetic ketoacidosis after initiation of an SGLT2 inhibitor","volume":"376","author":"Fralick","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0040","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.diabet.2019.01.001","article-title":"Clinical characteristics of diabetic ketoacidosis in users and non-users of SGLT2 inhibitors","volume":"45","author":"Jeon","year":"2019","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.117","article-title":"Prolonged glucosuria and relapse of diabetic ketoacidosis related to SGLT2-inhibitor therapy","volume":"3","author":"Westcott","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0050","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1377\/hlthaff.2010.0135","article-title":"Physicians\u2019 fears of malpractice lawsuits are not assuaged by tort reforms","volume":"29","author":"Carrier","year":"2010","journal-title":"Health Aff"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0055","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jamainternmed.2017.3919","article-title":"Use of health care databases to support supplemental indications of approved medications","volume":"178","author":"Fralick","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0307581","article-title":"Demographics, medication use, and admission characteristics of patients hospitalized with diabetes in Ontario, Canada: a retrospective cohort study","volume":"19","author":"Colacci","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcjd.2024.01.006","article-title":"Validation of the diagnostic accuracy levels of International Classification of Diseases-10 codes for diabetic ketoacidosis: a multicenter cross-sectional study","author":"Hodzic-Santor","year":"2024","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0075","article-title":"Diabetic ketoacidosis with SGLT2 inhibitors","volume":"371","author":"Musso","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0080","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1177\/09622802241244608","article-title":"The \u2018Why\u2019 behind including \u2018Y\u2019 in your imputation model","volume":"33","author":"D\u2019Agostino McGowan","year":"2024","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0085","author":"Risk Score Vignette"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0090","doi-asserted-by":"crossref","DOI":"10.2337\/db24-1896-LB","article-title":"1896-LB: clinical features and C-peptide levels associated with diabetic ketoacidosis in patients with type 2 diabetes on dapagliflozin vs. placebo\u2014insights from DECLARE-TIMI 58","volume":"73","author":"Mi Kang","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0095","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwae175.060","article-title":"Diabetic ketoacidosis in patients with type 2 diabetes mellitus receiving sodium-glucose co-transporter-2 inhibitors: The Hong Kong Diabetes Study","volume":"31","author":"Jing","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0100","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/bmj.327.7417.741","article-title":"Simple tools for understanding risks: from innumeracy to insight","volume":"327","author":"Gigerenzer","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0105","series-title":"NBER Working Paper","article-title":"Who is tested for heart attack and who should be: predicting patient risk and physician error","author":"Obermeyer","year":"2019"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0110","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.0956-7976.2004.00715.x","article-title":"Decisions from experience and the effect of rare events in risky choice","volume":"15","author":"Hertwig","year":"2004","journal-title":"Psychol Sci"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0115","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s13300-024-01550-5","article-title":"SGLT2 inhibitors \u2013 the new standard of care for cardiovascular, renal and metabolic protection in type 2 diabetes: a narrative review","volume":"15","author":"Seidu","year":"2024","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jdiacomp.2025.109144_bb0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jcjd.2021.10.001","article-title":"Sodium-glucose cotransporter-2 inhibitors increase risk of diabetic ketoacidosis in adults with type 2 diabetes: should we be concerned in people without diabetes?","volume":"46","author":"Goldenberg","year":"2022","journal-title":"Can J Diabetes"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725001977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725001977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:05:44Z","timestamp":1762362344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872725001977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1056872725001977"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109144","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting the occurrence of DKA following sodium glucose co-transporter-2 inhibitors: An international cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109144"}}